Page last updated: 2024-08-22

magnesium sulfate and Retrolental Fibroplasia

magnesium sulfate has been researched along with Retrolental Fibroplasia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Edwards, JM; Edwards, LE; Grotegut, CA; Swamy, GK	1
Ancel, PY; Benhammou, V; d'Ercole, C; Delorme, P; Foix-L'Hélias, L; Gire, C; Goffinet, F; Kayem, G; Lorthe, E; Marchand-Martin, L; Sentilhes, L; Subtil, D; Torchin, H; Winer, N	1
Basu, SK; Bhutada, A; Chickajajur, V; Lopez, V; Pagala, M; Rastogi, S	1

Trials

1 trial(s) available for magnesium sulfate and Retrolental Fibroplasia

Article	Year
Effect of Cord Blood Magnesium Level at Birth on Non-neurologic Neonatal Outcomes. American journal of perinatology, 2019, Volume: 36, Issue:1 Topics: Adult; Anticonvulsants; Bronchopulmonary Dysplasia; Cerebral Palsy; Enterocolitis, Necrotizing; Female; Fetal Blood; Humans; Infant, Newborn; Intellectual Disability; Magnesium; Magnesium Sulfate; Male; Outcome Assessment, Health Care; Pregnancy; Premature Birth; Retinopathy of Prematurity	2019

Article

Year

Effect of Cord Blood Magnesium Level at Birth on Non-neurologic Neonatal Outcomes.

American journal of perinatology, 2019, Volume: 36, Issue:1

Topics: Adult; Anticonvulsants; Bronchopulmonary Dysplasia; Cerebral Palsy; Enterocolitis, Necrotizing; Female; Fetal Blood; Humans; Infant, Newborn; Intellectual Disability; Magnesium; Magnesium Sulfate; Male; Outcome Assessment, Health Care; Pregnancy; Premature Birth; Retinopathy of Prematurity

2019

Other Studies

2 other study(ies) available for magnesium sulfate and Retrolental Fibroplasia

Article	Year
Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). American journal of obstetrics and gynecology, 2018, Volume: 219, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Cerebral Palsy; Cesarean Section; Child, Preschool; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Fetal Viability; France; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium Sulfate; Patient Transfer; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Prenatal Care; Retinopathy of Prematurity; Stillbirth; Survival Rate; Tocolysis; Tocolytic Agents	2018
Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection. Journal of perinatal medicine, 2011, Aug-11, Volume: 40, Issue:2 Topics: Cerebral Palsy; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Retinopathy of Prematurity; Retrospective Studies; Treatment Outcome	2011

Article

Year

Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).

American journal of obstetrics and gynecology, 2018, Volume: 219, Issue:3

Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Cerebral Palsy; Cesarean Section; Child, Preschool; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Fetal Viability; France; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium Sulfate; Patient Transfer; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Prenatal Care; Retinopathy of Prematurity; Stillbirth; Survival Rate; Tocolysis; Tocolytic Agents

2018

Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.

Journal of perinatal medicine, 2011, Aug-11, Volume: 40, Issue:2

Topics: Cerebral Palsy; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Retinopathy of Prematurity; Retrospective Studies; Treatment Outcome

2011